SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

AGM Trading Update

20 May 2025 07:00

RNS Number : 2492J
Forterra plc
20 May 2025
 

20 May 2025

FORTERRA PLC

 

AGM Trading Update

 

An encouraging start to the year

 

Ahead of our AGM which will be held today at 12.00pm in Northampton, Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the four-month period ended 30 April 2025 ('the Period').

 

Revenue in the Period of £124.1m was 22% ahead of the prior year (£102.0m) with a strong performance in both our Bricks and Blocks and Bespoke Products operating segments.

 

Trading saw continued positive momentum with the Group benefitting from an improving demand environment, primarily driven by housebuilding with RM&I demand remaining subdued. Our own performance is consistent with an improving market backdrop, in which domestic brick despatches to the end of March, as reported by the Department for Business and Trade, increased 17% year on year albeit against soft comparatives.

 

We continue to implement the necessary selling price increases to offset cost inflation, which remains at normalised levels in line with our expectations. With demand recovering and inventories reducing we are actively managing production capacity to ensure we continue to address customer demand. We have recently taken steps to increase our production of concrete floor beams, and we are preparing to increase our brick production at Desford and expect to utilise both kilns simultaneously for the first time from Q4 2025. Whilst full output is not yet required, this marks an important milestone in the ramp-up of this facility.

 

We have made good progress with the reinstatement of our Wilnecote brick factory following an investment of around £30m, with the kiln expected to be lit imminently. We expect to begin regaining our position in the attractive commercial and specification market as the year progresses. Similarly, the commissioning of our innovative brick slip production facility at our Accrington factory continues to progress in line with our expectations as we develop the product range ahead of a market launch later this year.

 

Notwithstanding normal seasonal trends, we continue to reduce our leverage, with net debt before leases at 30 April 2025 of £88.4m (31 December 2024: £84.9m) and 30 April 2024: £118.5m) equating to 1.7 times EBITDA on a rolling 12 months' banking covenant basis (31 December 2024: 1.9 times). 

 

Outlook

 

We are encouraged by the positive start to the year and expect to continue to benefit from an improving demand environment whilst noting that the prior year comparatives become more challenging as the year progresses. We remain mindful of the presently heightened global macro-economic uncertainty and the impact this could have on the wider economy. Accordingly, at this stage in the year, the Board's expectations for the Group's full year 2025 performance remain unchanged.

 

Our key markets continue to benefit from attractive fundamentals including the Government's commitment to materially increase housebuilding, although we remain mindful of the challenges in delivering this. Following our recent strategic investments in additional manufacturing capacity, the Group remains ideally positioned to benefit from continued market recovery.

 

ENQUIRIES

 

 

 

Forterra plc

+44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting

+44 203 727 1340

Richard Mountain / Nick Hasell

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTALMTTMTMBBMA
Date   Source Headline
28th Jan 20203:47 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
16th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20204:51 pmRNSEmployee Benefit Trust Share Purchase
6th Jan 202011:01 amRNSHolding(s) in Company
2nd Jan 20203:00 pmRNSCompany Secretary Change
2nd Jan 20207:00 amRNSHolding(s) in Company
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20194:36 pmRNSHolding(s) in Company
17th Dec 20198:57 amRNSDirector/PDMR Shareholding
16th Dec 20195:42 pmRNSHolding(s) in Company
11th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20197:00 amRNSBoard Changes
6th Dec 201910:46 amRNSDirector/PDMR Shareholding
4th Dec 201912:01 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20197:00 amRNSDirector/PDMR Shareholding
5th Nov 201912:38 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20199:51 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSTrading update
7th Oct 20192:03 pmRNSHolding(s) in Company
4th Oct 20192:09 pmRNSGrant of Options under 2018 SAYE Scheme
2nd Oct 20193:15 pmRNSEmployee Benefit Trust Share Purchase
26th Sep 20194:50 pmRNSEmployee Benefit Trust Share Purchase
9th Sep 20195:34 pmRNSDirector/PDMR Shareholding
4th Sep 20198:51 amRNSHolding(s) in Company
30th Jul 20197:00 amRNS2019 HALF YEAR RESULTS
4th Jul 201911:49 amRNSEmployee Benefit Trust Share Purchase
5th Jun 20199:20 amRNSEmployee Benefit Trust Share Purchase
20th May 20191:57 pmRNSResult of AGM
20th May 20197:00 amRNSAGM Trading Update
10th May 20193:08 pmRNSDirector/PDMR Shareholding
3rd May 20199:00 amRNSEmployee Benefit Trust Share Purchase
5th Apr 20192:50 pmRNSDirector/PDMR Shareholding
5th Apr 20192:49 pmRNSEmployee Benefit Trust Share Purchase
5th Apr 20191:21 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
2nd Apr 20193:58 pmRNSDirector/PDMR Shareholding
29th Mar 20199:11 amRNSGrant under Performance Share Plan
29th Mar 20199:10 amRNSGrant under Deferred Annual Bonus Plan
14th Mar 201911:28 amRNSEmployee Benefit Trust Share Purchase
12th Mar 201910:00 amRNSEmployee Benefit Trust Share Purchase
5th Mar 20198:45 amRNSEmployee Benefit Trust Share Purchase
8th Feb 20199:00 amRNSDirector Declaration
8th Feb 20197:00 amRNSAppointment of new Independent NED
6th Feb 20191:30 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20191:38 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20197:00 amRNSTrading Update
8th Jan 20199:27 amRNSEmployee Benefit Trust Share Purchase
19th Dec 201810:09 amRNSEmployee Benefit Trust Share Purchase
4th Dec 20182:27 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 201812:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.